Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).
Clinical trial NCT00087607 · COMPLETED
Trial details
- NCT number
- NCT00087607
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Primary completion
- 2006-03-01
- Enrollment
- 385
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.